Clinical Study
Prolonged Therapy with Imatinib Mesylate before Surgery for Advanced Gastrointestinal Stromal Tumor Results of a Phase II Trial
Table 1
Patients and tumour characteristics (
).
| | Characteristics | Number (range) |
| | Mean age (years) | 64 (39 to 84) | | Gender (male/female) | | | Male | 12 | | Female | 2 | | Tumour diameter (cm) | 9.4 (1.7 to 29) | | Disease status at diagnosis | — | | Locally advanced | 12 | | Local recurrence | 1 | | Metastatic | 1 | | Performance status at diagnosis (ECOG) | — | | 0 | 10 | | 1 | 2 | | 2 | 2
| | Disease location | — | | Stomach | 9 | | Duodenum | 2 | | Liver | 1 | | Oesophagus | 1 | | Rectum | 1 |
|
|
